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The ideal method of identifying frailty is uncertain, and data on long-term outcomes is relatively 
limited. We examined frailty indices derived from population-scale linked data on Intensive Care 
Unit (ICU) and hospitalised non-ICU patients with pneumonia to elucidate the influence of frailty 
on mortality. Longitudinal cohort study between 2010–2018 using population-scale anonymised 
data linkage of healthcare records for adults admitted to hospital with pneumonia in Wales. Primary 
outcome was in-patient mortality. Odds Ratios (ORs [95% confidence interval]) for age, hospital 
frailty risk score (HFRS), electronic frailty index (eFI), Charlson comorbidity index (CCI), and social 
deprivation index were estimated using multivariate logistic regression models. The area under the 
receiver operating characteristic curve (AUC) was estimated to determine the best fitting models. 
Of the 107,188 patients, mean (SD) age was 72.6 (16.6) years, 50% were men. The models adjusted 
for the two frailty indices and the comorbidity index had an increased odds of in-patient mortality 
for individuals with an ICU admission (ORs for ICU admission in the eFI model 2.67 [2.55, 2.79], HFRS 
model 2.30 [2.20, 2.41], CCI model 2.62 [2.51, 2.75]). Models indicated advancing age, increased frailty 
and comorbidity were also associated with an increased odds of in-patient mortality (eFI, baseline fit, 
ORs: mild 1.09 [1.04, 1.13], moderate 1.13 [1.08, 1.18], severe 1.17 [1.10, 1.23]. HFRS, baseline low, 
ORs: intermediate 2.65 [2.55, 2.75], high 3.31 [3.17, 3.45]). CCI, baseline < 1, ORs: ‘1–10′ 1.15 [1.11, 
1.20], > 10 2.50 [2.41, 2.60]). For predicting inpatient deaths, the CCI and HFRS based models were 
similar, however for longer term outcomes the CCI based model was superior. Frailty and comorbidity 
are significant risk factors for patients admitted to hospital with pneumonia. Frailty and comorbidity 
scores based on administrative data have only moderate ability to predict outcome.
Outcomes from critical illness among older patients and those with poorer health status are of increasing 
significance as global populations age, and have been the subject of intense interest during the SARS-CoV-2 
 pandemic1,2. Frailty is more common with increasing age and is often defined as a syndrome of physiological 
decline, characterised by marked vulnerability to adverse health  outcomes3,4. Frailty has been shown to modify 
the treatment effect of multiple high-risk interventions and independently predicts adverse outcomes beyond 
traditional comorbidities in several populations, including  pneumonia5.
The Clinical Frailty  Scale6 has been widely adopted in the acute setting as an easily applied judgement-based 
tool, and is specifically referenced within national COVID-19 decision-making  guidance7. It is often considered to 
be a composite assessment, which explicitly incorporates disability and the consequences of  comorbidity8. How-
ever, there is inherent subjectivity in such assessment, and we have previously described the limits to inter-rater 
reliability, and the need for training to enable consistent  application9. Overall, there remains some uncertainty 
about how best to identify frailty in relation to acute and critical  illness10,11.
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Alternative approaches to the identification of frailty which adopt a cumulative deficit model have recently 
been applied to UK National Health Service (NHS) electronic primary care data, the electronic frailty index 
(eFI)12, and to hospital records, the Hospital Frailty Risk Score (HFRS)13, but these measures have not been fully 
evaluated in a critical care setting. Pneumonia has historically been a major cause of  mortality14,15, a leading 
cause of sepsis, and one of the most common indications for critical care  admission16. A very recent US study 
indicated significant association of HFRS with 30-day mortality in older patients hospitalised with  pneumonia5, 
however data is currently limited regarding the predictive validity of frailty indices in relation to longer-term 
outcomes from critical illness.
In this study we aim to answer the following question: how is patient frailty and comorbidity, as identified 
by administrative tools, associated with inpatient, 6-month and 1-year mortality following hospitalisation with 
pneumonia?
Methods
Data sources. We used the Secure Anonymised Information Linkage (SAIL) Databank (www. saild ataba 
nk. com) to investigate short and long-term mortality in patients admitted with pneumonia to Welsh National 
Health Service (NHS) hospitals. The development of the SAIL Databank as a secure privacy protecting Trusted 
Research Environment (TRE) of anonymised person-based records has been described  previously17,18. The anal-
ysis of anonymised linked data was approved by the independent Information Governance Review Panel (IGRP) 
of the SAIL Collaboration Review System (Longitudinal analysis of Critical Care Outcomes in Wales, Project 
No: 0634, 20/06/2017).
We utilised the following data sources from the SAIL Databank in this retrospective cohort study: the Welsh 
Critical Care Dataset (CCDS, collated from the monthly exports of the Critical Care Minimum Dataset from all 
Welsh ICUs—including organ support, admission and discharge data), the Welsh Demographic Service Dataset 
(WDSD, demographic data submitted by primary care services), the Patient Episode Database for Wales (PEDW), 
Welsh Longitudinal General Practice (WLGP), and the Annual District Death Extract (ADDE) of the Office for 
National Statistics (ONS).
Study cohort. We used the PEDW inpatient data to identify patients admitted to hospital for the first time 
with a diagnosis of pneumonia or flu between 1st January 2010 and 31st December 2018. A pneumonia or flu 
diagnosis was defined using the International Coding of Disease version 10 (ICD-10) codes J09-J18. This data 
was linked with the WDSD to obtain the week of birth, sex and Lower Super Output Area (LSOA) of patient 
residence version 2011 (each LSOA contains approximately 1500 people) and onward linked to Welsh Index of 
Multiple Deprivation (WIMD) 2019 of each patient. We used week of birth to generate age on the admission date 
and included all patients aged 18-years or more. We identified patients with an ICU admission as those with an 
in-patient spell from PEDW that also contained a spell recorded in CCDS. Furthermore, we limited the cohort 
to those with high quality matching from the linkage and anonymisation process as previously  described18.
Assessment of comorbidity and frailty. Hospital frailty risk score. The Hospital Frailty Risk Score 
(HFRS) was developed using Hospital Episode Statistics (a database containing details of all admissions, Ac-
cident and Emergency (A&E) attendances and outpatient appointments at NHS hospitals in England), and vali-
dated on over 1-million older people admitted to hospitals in 2014/1513. The HFRS uses ICD-10 codes to search 
for specific conditions from secondary care. A weight is then applied to the conditions and a cumulative sum is 
used to determine a frailty status of: Low, Intermediate or  High13. We calculated the HFRS using PEDW on the 
date of admission, with a 2-year look back of all hospital admissions occurring in Wales.
electronic Frailty Index (eFI). The eFI is based on an internationally established cumulative deficit  model19, and 
assigns a frailty score to an individual calculated using 36 variables from primary care data including symptoms, 
signs, diseases, disabilities and abnormal laboratory values, referred to as  deficits12. The eFI score is the number 
of deficits present, expressed as an equally weighted proportion of the total. An individual with a single deficit 
would be assigned an eFI of 1/36 (0.03); another with nine deficits would be assigned an eFI of 9/36 (0.25). The 
eFI score is used to categorise individuals as: fit (eFI value of 0–0.12), mild (> 0.12–0.24), moderate (> 0.24–
0.36), or severely frail (> 0.36)12. We calculated the eFI retrospectively on the date of admission to hospital using 
10-years of previous WLGP data for each individual. As the eFI requires primary care data to be calculated, we 
restricted the analyses to only patients with a recorded WLGP registration during the hospital spell.
Charlson Comorbidity Index (CCI). The modified CCI was generated using the ICD-10 codes and weights 
detailed in the NHS Summary Hospital-level Mortality Indicator  specification20. ICD-10 codes relating to human 
immunodeficiency virus (HIV) are redacted from the data available within SAIL in accordance with SAIL poli-
cies, all other hospital admissions recorded in PEDW in the year preceding the discharge date were included in 
the CCI  calculation21. Scores were categorised into three groups: low (-1–0), medium (1–10) and high (> 10).
Outcomes of interest. The primary outcome was in-patient mortality. The secondary outcomes were 
6-month and 1-year mortality. We compared outcomes between those who had been admitted to ICU during 
the index hospitalisation and those who had not.
Statistical analysis. Basic demographic data are presented as counts, percentages and figures. To deter-
mine if the eFI, HFRS and CCI identify the same groups of individuals, we calculated the categorical scores 
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of both tools for each patient on the day before their index admission date. We then used Chi-squared tests to 
determine if the tools were associated, and Cramer’s V to determine the strength of association. To be consist-
ent with our methodology at specified time-points and determine associations we calculated multilevel logistic 
regression models for inpatient, 6-month, and 1-year mortality using a logit link function with mortality as the 
binary dependent variable. We created separate models for the eFI, HFRS and CCI. In each of the models we 
included the following variables as fixed effects: ICU admission, eFI (Fit, Mild, Moderate, Severe), HFRS (Low, 
Intermediate, High), CCI (< 1, 1–10, > 10), age (18–49, 50–59, 60–69, 70–79, 80 +), and sex (Male/Female). We 
included a random intercept for each admission year to account for potential changes in recording. Statistical 
analysis was performed using R version 4.0.0 and  R2MLwiN22. The best fitting logistic regression models were 
determined using the Area Under the receiver operating characteristic Curve (AUC).
Results
Participants. There were 133,604 index admissions for patients with pneumonia or flu to Welsh NHS hos-
pitals over the study period. As the eFI is calculated using primary care records the cohort was restricted to only 
include those registered with a general practice contributing data to SAIL in the study period (80%), this limited 
the cohort to 107,188 patients. The following flowchart demonstrates how the data for the ICU and hospital 
cohort was obtained (Fig. 1). Demographic and outcome distributions for the cohorts with and without general 
practice data are included in Table S1.
Figure 1.  CONSORT diagram for the number of patients in the study. eFI electronic Frailty Index; HFRS 
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Demographics and distribution of frailty and comorbidity according to eFI, HFRS and CCI. The 
demographic details of the patients are presented in Table 1. The non-ICU hospital admissions were dominated 
by those aged 80 years and over, whereas 50% of critical care patients were in the 60–79 year group. Higher levels 
of frailty defined by the eFI were seen in the non-ICU group, and only 23% of the ICU group were considered 
moderately or severely frail. Whereas the HFRS categorised a larger proportion of individuals as low risk in the 
non-ICU cohort, most ICU patients were considered “intermediate” risk. There were statistically significant, 
but clinically irrelevant differences in chronic illness prevalence, as quantified by the CCI, between ICU and 
non-ICU patients. Interestingly, patients with high comorbidity burden were represented identically between 
the ICU and non-ICU groups. ICU admissions were more likely to be from deprived areas compared with non-
ICU admissions. We also found an increase in frailty (eFI and HFRS) and comorbidities (CCI) with age (Fig. 2).
When examining crude 12-month mortality, we observed that in the low HFRS and low CCI categories mor-
tality was significantly higher in the patients admitted to the ICU in all age groups. In patients over 70 years of 
age, this gap between patients admitted or not admitted to the ICU has closed in the intermediate HFRS and CCI 
groups and disappeared in the high HFRS and high CCI groups (Supplementary Figure S1 and S2). In patients 
between 50 and 70 years of age the gap only closed in the high HFRS and CCI groups (Supplementary Figure S1 
and S2). We did not observe similar patterns using the eFI score (Supplementary Figure S3).
Association between eFI, HFRS and CCI. The cross tabulations for eFI, HFRS and CCI are included in the 
supplementary material (Supplementary Table S2–S4). Chi-squared tests for independence indicated that the 
eFI, HFRS and CCI were all associated (p < 0.001). Cramer’s V showed the strength of association was similar 
amongst all the tools, but strongest between the eFI and HFRS (0.255) and weaker between the CCI and frailty 
tools (eFI: 0.206, HFRS: 0.217) (Supplementary Table S5).
Risk factors of mortality at different time-points. Multivariate logistic regression analysis based on 
the two frailty indices and the comorbidity index consistently had an increased risk of inpatient, 6-month and 
1-year mortality for individuals with an ICU admission. Similarly, in all models, advancing age, increased frailty 
Table 1.  Cohort characteristics for the total population and stratified by patients admitted to an Intensive 
Care Unit (ICU) or not. Chi-squared tests were used for categorical variables and a t-test for the mean age to 
calculate p-values to determine statistically significant differences between demographic variables in the ICU 
and non-ICU admissions. Data presented as absolute counts, mean (SD) or percentages; ICU: Intensive Care 
Unit; WIMD: Welsh Index of Multiple Deprivation 2019.
Total Hospital admission ICU admission p-values
N 107,188 95,789 11,399
Sex
Female 50.0% 50.8% 44.0%
 < 0.001
Male 50.0% 49.2% 56.0%
Age (years) Mean (SD) 72.6 (16.6) 73.5 (16.5) 65.0 (15.7)  < 0.001
Age categories (years)
18–49 10.5% 9.8% 16.5%
 < 0.001
50–59 8.5% 7.7% 14.7%
60–69 15.4% 14.4% 23.7%
70–79 24.5% 24.2% 27.3%
80 + 41.1% 43.9% 17.7%
Electronic Frailty Index
Fit 26.8% 25.4% 38.7%
 < 0.001
Mild 35.8% 35.5% 38.0%
Moderate 26.3% 27.3% 18.0%
Severe 11.1% 11.8% 5.2%
Hospital Frailty Risk Score
Low 38.8% 40.1% 27.3%
 < 0.001Intermediate 40.1% 38.0% 57.4%
High 21.1% 21.8% 15.4%
Charlson Comorbidity Index
 < 1 32.5% 32.6% 31.6%
0.0401–10 29.7% 29.6% 30.6%
˃10 37.8% 37.8% 37.8%
WIMD 2019
1. Most deprived 23.6% 23.3% 25.6%
 < 0.001
2 22.2% 22.1% 22.9%
3 18.9% 18.9% 18.6%
4 17.5% 17.6% 16.5%
5. Least deprived 17.8% 18.0% 16.3%
Mortality
In-patient 23.9% 22.8% 33.5%  < 0.001
6-months 37.9% 37.6% 40.7%  < 0.001
1-year 43.7% 43.6% 44.5% 0.066
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and comorbidity burden together with residence in the most affluent areas affected short- and long-term mor-
tality. The estimated AUC revealed that each model had only moderate discriminatory power for predicting 
mortality. For predicting inpatient deaths, the CCI and HFRS based models were similar, however for longer 
term outcomes the CCI based model was superior to the frailty scores (Tables 2, 3, 4).
Discussion
In this population-scale, data linkage study, we examined in-patient and long-term mortality among patients 
hospitalised with pneumonia (including those admitted to ICU), to investigate the predictive validity of frailty 
assessment tools derived from administrative data. Our data indicates: that an in-patient hospital admission 
with pneumonia carries a high risk of death, with two out of five patients dying at 1-year; that eFI, HFRS and 
CCI identify different cohorts of patients within the ICU and non-ICU groups and has only moderate agreement 
between each other and that each investigated model has moderate predictive power for short- and long-term 
mortality, with the CCI based model showing best predictive ability at 1-year.
To the best of our knowledge, this is the largest dataset evaluating long-term outcomes for in-patient hospi-
talisations with pneumonia in relation to frailty. We examined mortality up until 1-year following hospitalisa-
tion. Unsurprisingly, patients admitted to ICU had significantly worse outcomes in the short-term. The biggest 
difference was observed for in-patient mortality, likely reflecting the impact of acute illness severity and need 
for invasive organ support. This is consistent with previous reports for pneumonia and  sepsis23,24. The overall 
in-patient mortality rates observed in our cohort (23.9%) are higher than a recent report from the US (12%), but 
similar to mortality rates in a German study from 2010- 11 (22%)25,26. Direct comparisons are made challenging 
by differences in study design, discharge destination and care administrative processes.
Given such an apparent susceptibility to poorer long-term outcomes, patients hospitalised with pneumonia 
are a relevant cohort in which to investigate characterisation and predictive validity of frailty scores. Since frailty 
measures which derive from administrative data may avoid the implementation burden of bedside assessment, 
reliance upon proxy information, and potential for recall bias, we utilised two measures we have previously vali-
dated in other NHS cohorts, the electronic frailty index (eFI) and Hospital Frailty Risk Score (HFRS)10,12,13,27,28.
Interestingly, we found that the eFI, which is probably closer to the theoretical description of an accumulated 
deficit frailty model, had only moderate agreement with HFRS categorisation in ICU and non-ICU groups. Most 
ICU patients were considered at intermediate risk according to HFRS but fit or only mildly frail according to 
eFI, whereas most non-ICU patients were low risk according to HFRS but had a higher proportion who would 
be considered moderate or severely frail according to eFI. Comorbidity was distributed evenly between ICU 
and non-ICU patients.
Figure 2.  Distribution of frailty and comorbidity categories by age in the cohort. eFI electronic Frailty Index; 
HFRS Hospital Frailty Risk Score; CCI Charlson comorbidity Index.
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Differences in characterisation within ICU and non-ICU groups according to frailty and comorbidity are not 
unexpected. A fair to moderate level of agreement between frailty assessment methods is not uncommon and our 
very recent direct comparison of hospitalised patients 65 years and over, also identified low correlation between 
eFI and  HFRS13,28. Consistent with previous studies, we observed significantly poorer outcomes with higher 
categories of frailty for eFI and HFRS among hospitalised patients – including those admitted to ICU—with the 
HFRS discriminating to a slightly greater degree than  eFI5,29.
Conceptualisation and measurement of frailty using retrospective healthcare records presents challenges for 
HFRS and eFI, each method is dependent upon the quality of coding; for eFI, the coding of deficits (from clinical 
features, specific illnesses, disabilities, and laboratory values) in primary care, and for HFRS the identification 
of specific conditions according to ICD-10 during hospitalisation. Maintaining consistency with a cumulative 
deficit model (with an absolute predicted risk), the eFI assigns equal weight to each variable, whereas HFRS 
produces a weighted  score12. The HFRS may miss elements which are important to consideration of frailty, 
such as polypharmacy or care  requirements13. The look back periods studied also differ by design: for eFI this 
was 10-years, and for HFRS 2-years28. This may have led to the exclusion of important conditions in HFRS pre-
dating hospital coding; alternatively, HFRS, with a shorter look back period, may have served as a more dynamic 
measure of immediately relevant conditions. Furthermore, important to note that although both the CCI and 
HFRS use ICD-10 codes, they express different risks prevalent in the same population. Whilst CCI is derived 
using ICD-10 codes of 17 comorbidities, the HFRS was developed giving weighting to 109 frailty-related ICD-10 
codes depending on their association with  frailty13,21. In a recent study in heart failure patients only moderate 
agreement was found between CCI and HFRS, although both scores were predictive of  outcome29.
A novel aspect of our study is the application of frailty assessment tools derived from administrative data in 
relation to ICU and non-ICU outcomes in pneumonia. Most previous studies reported intensive care outcomes 
according to the CFS and only two utilised a frailty index as predictor of long-term outcome: a 43-item tool 
derived from comprehensive geriatric assessment, and a novel 52-item instrument based upon data from patients 
admitted to a specialist geriatric  ICU30–32. Recent study of adult patients aged 18 years and over with pneumonia 
Table 2.  Odds Ratios (ORs) for the adjusted multilevel multivariate logistic regression inpatient mortality 
analyses. ICU Intensive Care Unit; CCI Charlson Comorbidity Index; eFI electronic Frailty Index; HFRS 
Hospital Frailty Risk Score; WIMD Welsh Index of Multiple Deprivation 2019; AUC Area Under the Curve.
CCI eFI HFRS
ICU admission 2.624 (2.505, 2.749) 2.669 (2.55, 2.794) 2.301 (2.197, 2.411)
Age category (years, baseline 18–49)
50–59 1.982 (1.782, 2.205) 2.278 (2.049, 2.532) 2.070 (1.861, 2.302)
60–69 2.999 (2.731, 3.294) 3.670 (3.341, 4.03) 3.208 (2.921, 3.523)
70–79 4.398 (4.021, 4.811) 5.598 (5.113, 6.13) 4.427 (4.048, 4.842)
80 + 8.665 (7.938, 9.458) 10.997 (10.051, 12.033) 7.422 (6.794, 8.108)
Sex (baseline—Female)
Male 1.034 (1.004, 1.066) 1.105 (1.073, 1.138) 1.119 (1.087, 1.153)
Charlson index (baseline—less than 1)
(1–10) 1.154 (1.107, 1.204) – –
 > 10 2.501 (2.409, 2.596) – –
electronic Frailty Index (baseline–fit)
Mild – 1.085 (1.040, 1.133) –
Moderate – 1.128 (1.078, 1.181) –
Severe – 1.165 (1.103, 1.231) –
HFRS (baseline – Low risk)
Intermediate – – 2.648 (2.548, 2.752)
High – – 3.306 (3.165, 3.452)
WIMD (Baseline—1. Most Deprived)
2 0.983 (0.941, 1.028) 0.975 (0.933, 1.018) 0.979 (0.937, 1.024)
3 0.927 (0.885, 0.971) 0.912 (0.872, 0.955) 0.940 (0.898, 0.985)
4 0.977 (0.933, 1.024) 0.962 (0.919, 1.007) 0.981 (0.936, 1.028)
5. Least Deprived 0.959 (0.916, 1.005) 0.953 (0.911, 0.998) 0.955 (0.912, 1.001)
Intercept 0.037 (0.032, 0.043) 0.042 (0.037, 0.049) 0.029 (0.025, 0.035)
Random effects
Variance 0.029 (0.002, 0.056) 0.028 (0.002, 0.055) 0.048 (0.003, 0.093)
– – – –
Observations 107,188 107,188 107,188
Groups (Admission Year) 9 9 9
AUC 0.711 (0.708, 0.715) 0.677 (0.674, 0.681) 0.711 (0.708, 0.714)
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admitted to Australia / New Zealand intensive care units found that only severe or very severe frailty scores 
(according to CFS) predicted in-hospital mortality; however, such patients will have been selected and ICU 
admission agreed on the basis of perceived likelihood of  benefit33. We found that short and long-term mortality 
was similar in the patients aged 70 years and over who had high frailty scores, whether they were admitted or 
not to the ICU. Our data further highlights the challenges faced by critical care teams in their management of 
an ageing and frail population.
An important further consideration is that eFI and HFRS were developed and validated in patient popula-
tions aged 65 years and over. However, the potential to assess physiological reserve and vulnerability to poorer 
outcomes for all hospitalised adults (and all age cohorts) is hugely appealing, and our study presents novel data 
with regards to the application of these frailty scores in younger patients. In our cohort, approximately one third 
of the patients were aged less than 65 and it is in this younger group that the frailty scores and the comorbidity 
evaluation showed the greatest divergence. Clearly, further work is required to establish how it may be possible 
to incorporate assessment of comorbidity and “frailty” determined on the basis of primary and/ or secondary 
care administrative data, among all age cohorts who may be admitted to critical care – and this seems likely to 
require the development of a new predictive model.
Limitations
Our study has limitations. The administrative in-patient data lacks detailed information about disease severity 
and medical treatments; comorbidities are dependent upon reliable ICD-10 coding, and variation in documenta-
tion and coding of diagnoses could contribute to measurement  error34. However, in Wales, routinely collected 
population-scale EHR data are sufficiently robust and accurate to be used in research or for health services 
 planning35. We could not analyse the direct impact of possible differences in treatment intensity during ICU 
admission, as comparative data are not available currently in the SAIL Databank in the hospital cohort. We 
were unable to examine long-term outcomes other than mortality, and it would be useful to explore how these 
frailty indices predict subsequent healthcare utilisation, physical function, disability and quality of  life31,36–38. 
Table 3.  Odds Ratios (ORs) for the adjusted multilevel multivariate logistic regression 6-month mortality 
analyses. ICU Intensive Care Unit; CCI Charlson Comorbidity Index; eFI electronic Frailty Index; HFRS 
Hospital Frailty Risk Score; WIMD Welsh Index of Multiple Deprivation 2019; AUC Area Under the Curve.
CCI eFI HFRS
ICU admission 1.670 (1.597, 1.746) 1.730 (1.657, 1.807) 1.450 (1.388, 1.516)
Age category (years, baseline 18–49)
50–59 2.316 (2.126, 2.523) 2.725 (2.505, 2.965) 2.522 (2.316, 2.746)
60–69 3.442 (3.189, 3.715) 4.346 (4.028, 4.688) 3.897 (3.613, 4.204)
70–79 4.871 (4.527, 5.241) 6.369 (5.915, 6.858) 5.231 (4.865, 5.625)
80 + 9.561 (8.902, 10.269) 12.174 (11.31, 13.104) 8.629 (8.032, 9.271)
Sex (baseline—Female)
Male 1.113 (1.084, 1.144) 1.205 (1.174, 1.237) 1.217 (1.185, 1.250)
Charlson index (baseline—less than 1)
(1–10) 1.208 (1.165, 1.252) – –
 > 10 3.178 (3.074, 3.285) – –
electronic Frailty Index (baseline—fit)
Mild – 1.111 (1.071, 1.153) –
Moderate – 1.194 (1.147, 1.243) –
Severe – 1.284 (1.222, 1.350) –
HFRS (baseline—Low risk)
Intermediate – – 2.485 (2.407, 2.566)
High – – 3.125 (3.009, 3.245)
WIMD (Baseline—1. Most Deprived)
2 1.007 (0.968, 1.049) 0.996 (0.958, 1.036) 1.001 (0.962, 1.042)
3 0.938 (0.900, 0.978) 0.919 (0.883, 0.957) 0.948 (0.910, 0.988)
4 1.008 (0.966, 1.051) 0.986 (0.946, 1.027) 1.007 (0.965, 1.050)
5. Least Deprived 0.939 (0.900, 0.980) 0.933 (0.896, 0.972) 0.934 (0.895, 0.974)
Intercept 0.064 (0.057, 0.071) 0.074 (0.067, 0.083) 0.055 (0.048, 0.063)
Random effects
Variance 0.018 (0.001, 0.035) 0.017 (0.001, 0.033) 0.031 (0.002, 0.061)
– – – –
Observations 107,188 107,188 107,188
Groups (Admission Year) 9 9 9
AUC 0.729 (0.727, 0.733) 0.683 (0.680, 0.687) 0.714 (0.712, 0.718)
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The observed higher mortality in the low frailty and comorbidity cohorts indicates that acute physiological 
disturbance leading to ICU admission will have significant effect on short-term outcomes. On the other hand, 
recent data, including ours, indicates that following ICU and hospital discharge, acute illness characteristics 
have diminishing impact on long-term  outcomes36,39–41. Future research should focus on exploring the utility 
of combining frailty instruments with age, comorbidity and illness severity data, and explore patient-centred 
outcomes other than mortality.
Conclusion
Patients admitted to hospital with pneumonia face a significant mortality risk in all age groups with less than 
three out of five alive at 1-year. When evaluating frailty assessment tools, HFRS and eFI performed differently in 
the ICU and non-ICU population, HFRS indicating higher risk amongst the ICU patients. Older patients with 
high frailty scores appear to have similarly poor outcomes with or without ICU admissions. Our results illustrate 
that there is value in the identification of frailty using indices derived from administrative data, but further work 
is needed to investigate how best to integrate such data, and to incorporate further with assessment of severity 
of acute illness and chronic comorbidity.
Data availability
The data that support the findings of this study are available from the Secure Anonymised Information Linkage 
Databank, but restrictions apply to the availability of these data, which were used under license for the current 
study, and so are not publicly available. Data are however available from the authors upon reasonable request 
and with permission of the Secure Anonymised Information Linkage Databank.
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Table 4.  Odds Ratios (ORs) for the adjusted multilevel multivariate logistic regression 1-year mortality 
analyses. ICU Intensive Care Unit; CCI Charlson Comorbidity Index; eFI electronic Frailty Index; HFRS 
Hospital Frailty Risk Score; WIMD Welsh Index of Multiple Deprivation 2019; AUC Area Under the Curve.
CCI eFI HFRS
ICU admission 1.537 (1.471, 1.607) 1.613 (1.545, 1.684) 1.328 (1.271, 1.387)
Age category (years, baseline 18–49)
50–59 2.374 (2.191, 2.571) 2.782 (2.572, 3.01) 2.612 (2.413, 2.828)
60–69 3.472 (3.232, 3.729) 4.340 (4.044, 4.659) 3.985 (3.713, 4.277)
70–79 5.094 (4.757, 5.455) 6.490 (6.057, 6.954) 5.514 (5.152, 5.901)
80 + 10.613 (9.927, 11.346) 12.869 (12.013, 13.786) 9.454 (8.84, 10.111)
Sex (baseline—Female)
Male 1.152 (1.122, 1.184) 1.256 (1.224, 1.29) 1.264 (1.231, 1.298)
Charlson index (baseline—less than 1)
(1–10) 1.267 (1.224, 1.312) – –
 > 10 3.466 (3.354, 3.583) – –
Electronic Frailty Index (baseline – fit)
Mild – 1.152 (1.111, 1.195) –
Moderate – 1.292 (1.242, 1.344) –
Severe – 1.464 (1.393, 1.539) –
HFRS (baseline—Low risk)
Intermediate – – 2.500 (2.424, 2.579)
High – – 3.413 (3.287, 3.544)
WIMD (Baseline—1. Most Deprived)
2 0.988 (0.949, 1.027) 0.978 (0.941, 1.016) 0.981 (0.943, 1.02)
3 0.924 (0.887, 0.963) 0.906 (0.87, 0.943) 0.934 (0.897, 0.974)
4 0.979 (0.939, 1.021) 0.958 (0.919, 0.998) 0.978 (0.938, 1.02)
5. Least Deprived 0.933 (0.895, 0.973) 0.929 (0.892, 0.967) 0.925 (0.887, 0.964)
Intercept 0.076 (0.068, 0.085) 0.089 (0.081, 0.099) 0.067 (0.059, 0.077)
Random effects
Variance 0.016 (0.001, 0.03) 0.015 (0.001, 0.029) 0.029 (0.002, 0.057)
– – – –
Observations 107,188 107,188 107,188
Groups (Admission Year) 9 9 9
AUC 0.742 (0.739, 0.745) 0.697 (0.694, 0.701) 0.728 (0.726, 0.732)
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